osteosarcoma
Showing 26 - 50 of 178
Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)
Suspended
- Osteosarcoma
- Recurrent Osteosarcoma
- Trastuzumab Deruxtecan
-
Birmingham, Alabama
- +27 more
Oct 21, 2022
Chemotherapy on Fertility in Osteosarcoma Survivors
Active, not recruiting
- Osteosarcoma
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +98 more
Oct 19, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)
Terminated
- Solid Tumors
- +2 more
- IBI188
- +5 more
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Oct 3, 2022
Osteosarcoma Trial in Italy (Mifamurtide arm, 3 drugs arm)
Active, not recruiting
- Osteosarcoma
- Mifamurtide arm
- 3 drugs arm
-
Candiolo, Torino, Italy
- +10 more
Sep 16, 2022
Patients With Osteosarcoma
Not yet recruiting
- Osteosarcoma
- (no location specified)
Sep 6, 2022
Pediatric PET/MR Image Registry
Recruiting
- Soft Tissue
- +2 more
- PET/MR imaging
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 9, 2022
Osteosarcoma, Ewing Sarcoma of Bone Trial in Warsaw (Regorafenib)
Recruiting
- Osteosarcoma
- Ewing Sarcoma of Bone
-
Warsaw, Mazovian, PolandMother and Child Institute
Sep 7, 2022
Participated in Children's Oncology Group Studies
Recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- Assessment of Therapy Complications
- Questionnaire Administration
-
Birmingham, Alabama
- +163 more
Sep 6, 2022
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Osteosarcoma Trial in United States (Avelumab, Questionnaires)
Active, not recruiting
- Osteosarcoma
- Avelumab
- Questionnaires
-
Los Angeles, California
- +3 more
Aug 22, 2022
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Drug Sensitivity and Mutation Profiling
Recruiting
- Ewing Sarcoma
- +6 more
-
Miami, FloridaNicklaus Children's Hospital
Aug 5, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Solid Tumor, Adult, Triple Negative Breast Cancer, Colorectal Cancer Trial in Scottsdale, La Jolla, Stanford (CRX100 suspension
Recruiting
- Solid Tumor, Adult
- +6 more
- CRX100 suspension for infusion
-
Scottsdale, Arizona
- +2 more
Jul 26, 2022
Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers Trial in New York (Humanized 3F8 Bispecific Antibody, Blood draw)
Terminated
- Neuroblastoma
- +2 more
- Humanized 3F8 Bispecific Antibody
- Blood draw
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 11, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Osteosarcoma Trial in Seattle (SCRI-E2CAR_EGFRtv1, UB_TT170)
Recruiting
- Osteosarcoma
- SCRI-E2CAR_EGFRtv1
- UB_TT170
-
Seattle, WashingtonSeattle Children's Hospital
May 31, 2022
Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,
Active, not recruiting
- Adrenal Cortex Carcinoma
- +39 more
- Cabozantinib
- +2 more
-
Birmingham, Alabama
- +142 more
May 24, 2022
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
- Cancer
- +7 more
- Blood sampling
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 17, 2022
Osteosarcoma Trial in New York (L-MTP-PE)
Available
- Osteosarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
May 19, 2022